Utrecht Cardiovascular Cohort - The Second Manifestations of ARTerial disease Study

Utrecht Cardiovascular Cohort - The Second Manifestations of ARTerial disease Study - UCC-SMART

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON54646

Enrollment

16227

Registered

2014-11-05

Start date

2014-11-12

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial infarction Stroke Vascular disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Stroke or TIA Myocardial Infarction PTCA Hypertension Hyperlipidemia Aorta aneurysm Diabetes Pre-eclampsia and premature birth in history HIV

Exclusion criteria

Exclusion criteria: pregnancy Rankin >3 life-expectancy less than 1 year

Design outcomes

Primary

Measure	Time frame
"Endpoints" are unwanted vascular complications, which should be prevented by the treatment given to the patient. Possible endpoints which are reported in the six months follow-up are objectified by requesting clinical information of the treating specialist or GP. Each reported endpoint follows an verification procedure. All data of that endpoint are presented independently to three members of the endpoint committee. Each member gives a classification to the endpoint and the classifications are compared. If the members disagree, that particular endpoint will be discussed with the principal investigators. The endpoints are: • Stroke • Myocardial infarction • Heart failure • Amputation • aortic rupture • Vascular Intervention • Vascular Intervention of an intracranial aneurysm • ESRD • Bleeding • Retinal haemorrhages and infarctions • Diabetes • Dementia • Death	—

Measure

Time frame

"Endpoints" are unwanted vascular complications, which should be prevented by the treatment given to the patient. Possible endpoints which are reported in the six months follow-up are objectified by requesting clinical information of the treating specialist or GP. Each reported endpoint follows an verification procedure. All data of that endpoint are presented independently to three members of the endpoint committee. Each member gives a classification to the endpoint and the classifications are compared. If the members disagree, that particular endpoint will be discussed with the principal investigators. The endpoints are: • Stroke • Myocardial infarction • Heart failure • Amputation • aortic rupture • Vascular Intervention • Vascular Intervention of an intracranial aneurysm • ESRD • Bleeding • Retinal haemorrhages and infarctions • Diabetes • Dementia • Death

—

Countries

Netherlands

Outcome results